Hisato Kawakami

Presentation(s):

• SO-8: Soluble programmed cell death ligand 1 associated with clinical outcome in gastric cancer patients treated with nivolumab: Blood based biomarker analysis of DELIVER trial (JACCRO-GC08AR)

  Thursday, June 30, 2022
  09:06 – 09:14